NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  222.65
+0.11 (0.05%)
AAPL  273.22
-0.89 (-0.32%)
AMD  207.11
-0.47 (-0.23%)
BAC  55.12
-0.20 (-0.37%)
GOOG  308.96
-0.36 (-0.12%)
META  650.91
+3.40 (0.53%)
MSFT  474.07
-0.75 (-0.16%)
NVDA  176.68
+0.39 (0.22%)
ORCL  186.88
+1.96 (1.06%)
TSLA  476.61
+1.30 (0.27%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.